Receptor protein-tyrosine phosphatase gamma is a candidate tumor suppressor gene at human chromosome region 3p21
- PMID: 1711217
- PMCID: PMC51802
- DOI: 10.1073/pnas.88.11.5036
Receptor protein-tyrosine phosphatase gamma is a candidate tumor suppressor gene at human chromosome region 3p21
Abstract
PTPG, the gene for protein-tyrosine phosphatase gamma (PTP gamma), maps to a region of human chromosome 3, 3p21, that is frequently deleted in renal cell carcinoma and lung carcinoma. One of the functions of protein-tyrosine phosphatases is to reverse the effect of protein-tyrosine kinases, many of which are oncogenes, suggesting that some protein-tyrosine phosphatase genes may act as tumor suppressor genes. A hallmark of tumor suppressor genes is that they are deleted in tumors in which their inactivation contributes to the malignant phenotype. In this study, one PTP gamma allele was lost in 3 of 5 renal carcinoma cell lines and 5 of 10 lung carcinoma tumor samples tested. Importantly, one PTP gamma allele was lost in three lung tumors that had not lost flanking loci. PTP gamma mRNA was expressed in kidney cell lines and lung cell lines but not expressed in several hematopoietic cell lines tested. Thus, the PTP gamma gene has characteristics that suggest it as a candidate tumor suppressor gene at 3p21.
Similar articles
-
The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.Cancer Res. 2000 Nov 1;60(21):6116-33. Cancer Res. 2000. PMID: 11085536
-
Molecular analysis of the protein tyrosine phosphatase gamma gene in human lung cancer cell lines.Cancer Res. 1992 Jun 15;52(12):3506-9. Cancer Res. 1992. PMID: 1596910
-
HD-PTP: A novel protein tyrosine phosphatase gene on human chromosome 3p21.3.Biochem Biophys Res Commun. 2000 Nov 30;278(3):671-8. doi: 10.1006/bbrc.2000.3870. Biochem Biophys Res Commun. 2000. PMID: 11095967
-
Hot spots for molecular genetic alterations in lung cancer.In Vivo. 1998 Nov-Dec;12(6):643-58. In Vivo. 1998. PMID: 9891228 Review.
-
Molecular analysis of deletions in human chromosome 3p21 and the role of resident cancer genes in disease.Brief Funct Genomic Proteomic. 2007 Mar;6(1):19-39. doi: 10.1093/bfgp/elm007. Epub 2007 May 24. Brief Funct Genomic Proteomic. 2007. PMID: 17525073 Review.
Cited by
-
A human transmembrane protein-tyrosine-phosphatase, PTP zeta, is expressed in brain and has an N-terminal receptor domain homologous to carbonic anhydrases.Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7417-21. doi: 10.1073/pnas.89.16.7417. Proc Natl Acad Sci U S A. 1992. PMID: 1323835 Free PMC article.
-
Receptor protein tyrosine phosphatase from stem cells to mature glial cells of the central nervous system.J Mol Neurosci. 2006;29(3):241-55. doi: 10.1385/JMN:29:3:241. J Mol Neurosci. 2006. PMID: 17085782 Review.
-
DDIAS promotes STAT3 activation by preventing STAT3 recruitment to PTPRM in lung cancer cells.Oncogenesis. 2020 Jan 2;9(1):1. doi: 10.1038/s41389-019-0187-2. Oncogenesis. 2020. PMID: 31900385 Free PMC article.
-
Expression of the receptor-linked protein tyrosine phosphatase LAR: proteolytic cleavage and shedding of the CAM-like extracellular region.EMBO J. 1992 Mar;11(3):897-907. doi: 10.1002/j.1460-2075.1992.tb05128.x. EMBO J. 1992. PMID: 1547787 Free PMC article.
-
Receptor protein tyrosine phosphatases and cancer: new insights from structural biology.Cell Adh Migr. 2012 Jul-Aug;6(4):356-64. doi: 10.4161/cam.21242. Epub 2012 Jul 1. Cell Adh Migr. 2012. PMID: 22796942 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases